Roivant Sciences (ROIV) Cost of Revenue (2020 - 2025)
Historic Cost of Revenue for Roivant Sciences (ROIV) over the last 6 years, with Q4 2025 value amounting to $700000.0.
- Roivant Sciences' Cost of Revenue rose 17027.03% to $700000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $1.2 million, marking a year-over-year increase of 3554.82%. This contributed to the annual value of $911000.0 for FY2025, which is 4302.69% down from last year.
- Roivant Sciences' Cost of Revenue amounted to $700000.0 in Q4 2025, which was up 17027.03% from $111000.0 recorded in Q3 2025.
- Roivant Sciences' Cost of Revenue's 5-year high stood at $6.4 million during Q3 2021, with a 5-year trough of $111000.0 in Q3 2025.
- Its 5-year average for Cost of Revenue is $1.6 million, with a median of $700000.0 in 2025.
- In the last 5 years, Roivant Sciences' Cost of Revenue surged by 79244.76% in 2021 and then plummeted by 9494.54% in 2024.
- Over the past 5 years, Roivant Sciences' Cost of Revenue (Quarter) stood at $1.4 million in 2021, then skyrocketed by 159.1% to $3.6 million in 2022, then tumbled by 94.51% to $197000.0 in 2023, then soared by 31.47% to $259000.0 in 2024, then soared by 170.27% to $700000.0 in 2025.
- Its Cost of Revenue stands at $700000.0 for Q4 2025, versus $111000.0 for Q3 2025 and $154000.0 for Q2 2025.